ER 4 2.25 (Pramipexole Dihydrochloride Extended-Release 2.25 mg)
Pill with imprint ER 4 2.25 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 2.25 mg. It is supplied by Macleods Pharmaceuticals Limited.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 2.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ER 4 2.25
Pramipexole Dihydrochloride Extended-Release
- Imprint
- ER 4 2.25
- Strength
- 2.25 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Macleods Pharmaceuticals Limited
- National Drug Code (NDC)
- 33342-0211
- Inactive Ingredients
-
hypromelloses,
mannitol,
corn starch,
carbomer homopolymer type c (allyl pentaerythritol crosslinked),
magnesium stearate,
silicon dioxide
Note: Inactive ingredients may vary.
Related Images for "ER 4 2.25"
More about pramipexole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 195 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Pramipexole (Advanced Reading)
- Pramipexole Extended-Release Tablets
- Pramipexole Tablets
- Other brands
- Mirapex, Mirapex ER
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.